<DOC>
	<DOCNO>NCT00154011</DOCNO>
	<brief_summary>The study design test hypothesis healthy subject oral antidiabetic drug rosiglitazone provide additional vascular relax modulate effect addition blood glucose level reduce ability .</brief_summary>
	<brief_title>Investigation Vascular Relaxing Effects Antidiabetic Rosiglitazone .</brief_title>
	<detailed_description>The aim study investigate effect oral rosiglitazone therapy vascular responsiveness different vasoactive compound ( angiotensin II , insulin , histamine glyceroltrinitrate ) healthy subject . Rosiglitazone give orally ( 4 week 4mg/d , titrate 8 mg/d another 4 week ) treatment . Every subject receive intravenous stimulation angiotensin II , histamine , insulin glyceroltrinitrate 8 week treatment interval rosiglitazone .</detailed_description>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Male Healthy 18 40 year old Nonsmoker No additional medication Any relevant disease Smokers Elevated liver enzymes Body weight different Broca norm &gt; 20 % Allergies</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>vascular reactivity , venodilation</keyword>
</DOC>